SRM - MS analysis will permit us to
directly use small - sized samples, such as the individual CSF samples, enable verification of
marker candidates that currently do not have available antibodies (hence not amenable to conventional analyses such as ELISA or Western blots), and provide robust statistical analyses on individual candidate
markers or combinations of them to determine which would make the best biomarker (s) for a particular
disease condition.